β-淀粉样蛋白PET与123I-FP-CIT SPECT在路易体痴呆风险轻度认知障碍中的特征
研究纳入34例具有至少1个路易体痴呆核心临床特征的轻度认知障碍患者,按PiB PET(A+阈值SUVR≥1.48)和123I-FP-CIT SPECT(D+阈值壳核z值<-0.82)分组。最常见为A-D+(38.2%),其次A+D+和A-D-(各26.5%),A+D-最少(8.8%)。A+组年龄更大、APOE ε4携带率更高、MMSE评分更低;D+组更可能有 probable REM睡眠行为障碍。较低壳核z值和较低PiB SUVR独立与较高UPDRS-III评分相关。
要点
- MCI-LB患者中最常见生物标志物组合为A-D+(低淀粉样蛋白、多巴胺活性降低)。
- A+与年龄更大、APOE ε4携带率更高及MMSE评分更低相关。
- D+与probable REM睡眠行为障碍可能性更高相关。
核心结论
- 多数MCI-LB患者表现为低β-淀粉样蛋白沉积和多巴胺能活性降低。
- β-淀粉样蛋白PET与123I-FP-CIT SPECT在刻画MCI-LB临床表型方面具有互补性。
研究设计与样本
- 研究纳入34例具有至少1个路易体痴呆核心临床特征的轻度认知障碍患者。
- 根据预先设定的异常截断值将患者分为A+(PiB SUVR≥1.48)或A-、D+(壳核z值<-0.82)或D-,并归入四种生物标志物组合。
主要发现
- A-D+组合最常见(38.2%),其次为A+D+(26.5%)和A-D-(26.5%),A+D-最少(8.8%)。
- A+组较A-组年龄更大、APOE ε4携带频率更高、MMSE评分更低。
- D+组较D-组更可能有probable REM睡眠行为障碍。
- 较低壳核DaTQUANT z值和较低PiB SUVR独立与较高UPDRS-III评分相关。
关键数值与推荐
- A+判定阈值:PiB PET SUVR≥1.48。
- D+判定阈值:123I-FP-CIT SPECT壳核DaTQUANT z值<-0.82。
临床怎么用
- 对具有路易体痴呆核心特征的MCI患者,可联合β-淀粉样蛋白PET与123I-FP-CIT SPECT进行生物标志物分型。
- 生物标志物分型有助于识别不同临床表型,如A+与认知功能更低相关、D+与REM睡眠行为障碍相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the clinical phenotypes associated with the β-amyloid PET and dopamine transporter imaging (123I-FP-CIT SPECT) findings in mild cognitive impairment (MCI) with the core clinical features of dementia with Lewy bodies (DLB; MCI-LB). METHODS: Patients with MCI who had at least 1 core clinical feature of DLB (n = 34) were grouped into β-amyloid A+ or A- and 123I-FP-CIT SPECT D+ or D- groups based on previously established abnormality cut points for A+ with Pittsburgh compound B PET standardized uptake value ratio (PiB SUVR) ≥1.48 and D+ with putamen z score with DaTQUANT <-0.82 on 123I-FP-CIT SPECT. Individual patients with MCI-LB fell into 1 of 4 groups: A+D+, A+D-, A-D+, or A-D-. Log-transformed PiB SUVR and putamen z score were tested for associations with patient characteristics. RESULTS: The A-D+ biomarker profile was most common (38.2%), followed by A+D+ (26.5%) and A-D- (26.5%). The least common was the A+D- biomarker profile (8.8%). The A+ group was older, had a higher frequency of APOE ε4 carriers, and had a lower Mini-Mental State Examination score than the A- group. The D+ group was more likely to have probable REM sleep behavior disorder. Lower putamen DaTQUANT z scores and lower PiB SUVRs were independently associated with higher Unified Parkinson's Disease Rating Scale-III scores. CONCLUSIONS: A majority of patients with MCI-LB are characterized by low β-amyloid deposition and reduced dopaminergic activity. β-Amyloid PET and 123I-FP-CIT SPECT are complementary in characterizing clinical phenotypes of patients with MCI-LB.
引用
- Chen Q, Lowe VJ, Boeve BF, et al. β-Amyloid PET and 123I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia. Neurology. 2021. PMID: 33408148. doi:10.1212/WNL.0000000000011454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。